1. Home
  2. CRIS vs MASK Comparison

CRIS vs MASK Comparison

Compare CRIS & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • MASK
  • Stock Information
  • Founded
  • CRIS 2000
  • MASK 2017
  • Country
  • CRIS United States
  • MASK China
  • Employees
  • CRIS N/A
  • MASK N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • MASK
  • Sector
  • CRIS Health Care
  • MASK
  • Exchange
  • CRIS Nasdaq
  • MASK NYSE
  • Market Cap
  • CRIS 32.8M
  • MASK 31.7M
  • IPO Year
  • CRIS 2000
  • MASK 2025
  • Fundamental
  • Price
  • CRIS $3.21
  • MASK $2.65
  • Analyst Decision
  • CRIS Strong Buy
  • MASK
  • Analyst Count
  • CRIS 3
  • MASK 0
  • Target Price
  • CRIS $23.00
  • MASK N/A
  • AVG Volume (30 Days)
  • CRIS 33.8K
  • MASK 91.8K
  • Earning Date
  • CRIS 02-18-2025
  • MASK 01-01-0001
  • Dividend Yield
  • CRIS N/A
  • MASK N/A
  • EPS Growth
  • CRIS N/A
  • MASK 55.43
  • EPS
  • CRIS N/A
  • MASK 0.15
  • Revenue
  • CRIS $10,259,000.00
  • MASK $4,561,963.00
  • Revenue This Year
  • CRIS N/A
  • MASK N/A
  • Revenue Next Year
  • CRIS N/A
  • MASK N/A
  • P/E Ratio
  • CRIS N/A
  • MASK $17.05
  • Revenue Growth
  • CRIS 0.44
  • MASK 172.95
  • 52 Week Low
  • CRIS $2.86
  • MASK $2.50
  • 52 Week High
  • CRIS $17.49
  • MASK $3.99
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 43.98
  • MASK N/A
  • Support Level
  • CRIS $3.05
  • MASK N/A
  • Resistance Level
  • CRIS $3.55
  • MASK N/A
  • Average True Range (ATR)
  • CRIS 0.22
  • MASK 0.00
  • MACD
  • CRIS 0.00
  • MASK 0.00
  • Stochastic Oscillator
  • CRIS 26.67
  • MASK 0.00

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About MASK 3 E NETWORK TECHNOLOGY GROUP LTD

3 E Network Technology Group Ltd is a business-to-business ("B2B") information technology ("IT") business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.

Share on Social Networks: